Antigua and Barbuda vs Lebanon: Mortality rate attributed to cardiovascular disease, cancer, diabetes
Antigua and Barbuda
12.1
in 2021
Lebanon
11.9
in 2021
Antigua and Barbuda rank
154th
Lebanon rank
157th
Mortality rate attributed to cardiovascular disease, cancer, diabetes over time
- Antigua and Barbuda
- Lebanon
How they compare
Antigua and Barbuda currently reports 12.1 against 11.9 in Lebanon, a difference of 0.2.
Across all 7 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 154th and Lebanon ranks 157th of 197 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.15 | 15.95 | 2.2 | Antigua and Barbuda |
| 2010s | 17.9 | 13.27 | 4.63 | Antigua and Barbuda |
| 2020s | 13.55 | 12.3 | 1.25 | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality rate attributed to cardiovascular disease, cancer, diabetes, Antigua and Barbuda or Lebanon?
- Antigua and Barbuda, at 12.1 against 11.9 in Lebanon as of 2021.
- What is the difference in mortality rate attributed to cardiovascular disease, cancer, diabetes between Antigua and Barbuda and Lebanon?
- 0.2, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Lebanon?
- 7 years are reported by both, from 2000 to 2021.
- How do Antigua and Barbuda and Lebanon rank globally for mortality rate attributed to cardiovascular disease, cancer, diabetes?
- Antigua and Barbuda ranks 154th and Lebanon ranks 157th of 197 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease (probability). Statizoid refreshes it automatically from the source and publishes the full history for both places.